2024 εΉ΄ 1 月 8 ζ—₯ζ›΄ζ–°

総θͺ¬ [θ‹±ζ–‡]

  1. H. Cabral, J. Li, K. Miyata, K. Kataoka, Controlling the biodistribution and clearance of nanomedicines. Nat. Rev. Bioeng. in press
  2. Y. Han, P. Wen, J. Li, K. Kataoka, Targeted nanomedicine in cisplatin-based cancer therapeutics. J. Control. Release 345 709-720 (2022) (DOI: 10.1016/j.jconrel.2022.03.049)
  3. S. Quader, K. Kataoka, H. Cabral, Nanomedicine for brain cancer. Adv. Drug Deliv. Rev. 182 114115 (2022) (DOI: 10.1016/j.addr.2022.114115)
  4. P. Mi, K. Miyata, K. Kataoka, H. Cabral, Clinical translation of self-assembled cancer nanomedicines. Adv. Therap. 4 Issue 1 2000159 (2021) (DOI: 10.1002/adtp.202000159)
    ▶ Cover Picture
  5. J. Li, K. Kataoka, Chemo-physical strategies to advance the in Vivo functionality of targeted nanomedicine: The next generation. J. Am. Chem. Soc. 143 2 538-559 (2021) (DOI: 10.1021/jacs.0c09029)
  6. H. Cabral, H. Kinoh, K. Kataoka, Tumor-targeted nanomedicine for immunotherapy. Acc. Chem. Res. 53(12) 2765-2776 (2020) (DOI: 10.1021/acs.accounts.0c00518)
    ▶ Supplementary Cover
  7. H. Cabral, K. Kataoka, Erythrocyte depletion lifts nanoparticle half-lives. Nature Biomed. Eng. 4 670-671 (2020) (DOI: 10.1038/s41551-020-0586-x)
  8. P. Mi, H. Cabral, K. Kataoka, Ligand-installed nanocarriers towards precision therapy. Adv. Mater. 32(13) 1902604 (2020) (DOI: 10.1002/adma.201902604)
  9. J. Xie, Z. Shen, Y. Anraku, K. Kataoka, X. Chen, Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. Biomaterials 224 119491 (2019) (DOI: 10.1016/j.biomaterials.2019.119491)
  10. S. -L. Kwon, H. -W. Ko, D. -G. You, K. Kataoka, J. -H. Park, Nanomedicines for reactive oxygen species mediated approach: An emerging paradigm for cancer treatment. Acc. Chem. Res. 52(7) 1771-1782 (2019) (DOI: 10.1021/acs.accounts.9b00136)
  11. K. Kataoka, Chemistry enabling β€œmagic bullet”. L'Act. Chim. 442 July-August 2019 5-7 (2019)
  12. S. Uchida, K. Kataoka, Design concepts of polyplex micelles for in vivo therapeutic delivery of plasmid DNA and messenger RNA. J. Biomed. Mater. Res. A 107(5) 978-990 (2019) (DOI: 10.1002/jbm.a.36614)
  13. J. F. Mukerabigwi, Z. Ge, K. Kataoka, Therapeutic nanoreactors as in vivo nanoplatforms for cancer therapy. Chem. Eur. J. 24(59) 15706-15724 (2018) (DOI: 10.1002/chem.201801159)
  14. H. Cabral, K. Miyata, K. Osada, K. Kataoka, Block copolymer micelles in nanomedicine applications. Chem. Rev. 118 (14) 6844-6892 (2018) (DOI: 10.1021/acs.chemrev.8b00199)
  15. A. Harada, K. Kataoka, Polyion complex micelle formation from double-hydrophilic block copolymers composed of charged and non-charged segments in aqueous media. Polymer J. 50 95-100 (2018) (DOI: 10.1038/pj.2017.67)
  16. Y. Mochida, H. Cabral, K. Kataoka, Polymeric micelles for targeted tumor therapy of platinum anticancer drugs. Expert Opin. Drug Deliv. 14(12) 1423-1438 (2017) (DOI: 10.1080/17425247.2017.1307338)
  17. S. Quader, K. Kataoka, Nanomaterial-enabled cancer therapy. Mol Ther. 25(7) 1501-1513 (2017) (DOI: 10.1016/j.ymthe.2017.04.026)
  18. B. Pelaz, C. Alexiou, R. A. A-Puebla, F. Alves, A. M. Andrews, S. Ashraf, L. P. Balogh, L. Ballerini, A. Bestetti, C. Brendel, S. Bosi, M. Carril, W. C. W. Chan, C. Chen, X. Chen, X. Chen, Z. Cheng, D. Cui, J. Du, C. Dullin, A. Escudero, N. Feliu, M. Gao, M. George, Y. Gogotsi, A. Grünweller, Z. Gu, N. J. Halas, N. Hampp, R. K. Hartmann, M. C. Hersam, P. Hunziker, J. Jian, X. Jiang, P. Jungebluth, P. Kadhiresan, K. Kataoka, A. Khademhosseini, J. Kopeček, N. A. Kotov, H. F. Krug, D. -S. Lee, C.-M. Lehr, K. W. Leong, X.-J. Liang, M. L. Lim, L. M. L-Marzán, X. Ma, P. Macchiarini, H. Meng, H. Möhwald, P. Mulvaney, A. E. Nel, S. Nie, P. Nordlander, T. Okano, J. Oliveira, T. -H. Park, R. M. Penner, M. Prato, V. Puntes, V. M. Rotello, A. Samarakoon, R. E. Schaak, Y. Shen, S. Sjöqvist, A. G. Skirtach, M. G. Soliman, M. M. Stevens, H. -W. Sung, B. Z. Tang, R. Tietze, B. N. Udugama, J. S. VanEpps, T. Weil, P. S. Weiss, I. Willner, Y. Wu, L. Yang, Z. Yue, Q. Zhang, Q. Zhang, X.-E. Zhang, Y. Zhao, Z. Zhou, W. J. Parak, Diverse applications of nanomedicine. ACS Nano 11 (3) 2313-2381 (2017) (DOI: 10.1021/acsnano.6b06040)
  19. H. -J. Kim, A. Kim, K. Miyata, K. Kataoka, Recent progress in development of siRNA delivery vehicles for cancer therapy. Adv. Drug Deliv. Rev. 104 61-77 (2016) (DOI: 10.1016/j.addr.2016.06.011)
  20. N. Nishiyama, Y. Matsumura, K. Kataoka, Development of polymeric micelles for targeting intractable cancers. Cancer Sci. 107 (7) 867-874 (2016) (DOI: 10.1111/cas.12960)
  21. S. Mitragotri, D. G. Anderson, X. Chen, E. K. Chow, D. Ho, A. V. Kabanov, J. M. Karp, K. Kataoka, C. A. Mirkin, S. H. Petrosko, J. Shi, M. M. Stevens, S. Sun, S. Teoh, S. S. Venkatraman, Y. Xia, S. Wang, Z. Gu, C. Xu, Accelerating the translation of nanomaterials in biomedicine. ACS Nano 9 (7) 6644-6654 (2015) (DOI: 10.1021/acsnano.5b03569)
  22. K. S. -Kato, N. Nishiyama, M. Kozaki, T. Nakanishi, Y. Matsuda, M. Hirano, H. Hanada, S. Hisada, H. Onodera, H. Harashima, Y. Matsumura, K. Kataoka, Y. Goda, H. Okuda, T. Kawanishi, General considerations regarding the in vitro and in vivo properties of block copolymer micelle products and their evaluation. J. Control. Release 210 76-83 (2015) (DOI: 10.1016/j.jconrel.2015.05.259)
  23. H. Cabral, K. Kataoka, 22. The impact of "Development of the polymer micelles carrier system for doxorubicin" on the nanomedicine realm: Original Research Article: Development of the polymer micelle carrier system for doxorubicin, 2001. J. Control. Release 190 70-72 (2014) (DOI: 10.1016/j.jconrel.2014.07.034)
  24. Progress of drug-loaded polymeric micelles into clinical studies. H. Cabral, K. Kataoka, J. Control. Release 190 465-476 (20149 (DOI: 10.1016/j.jconrel.2014.06.042)
  25. A. Matsumoto, K. Kataoka, Y. Miyahara, New directions in the design of phenylboronate-functionalized polymers for diagnostic and therapeutic applications. Polymer J. 46 (8) 483-491 (2014) (DOI: 10.1038/pj.2014.42)
  26. H. Cabral, K. Kataoka, Bridging polymer science and medicine through supramolecular nanoassemblies. Adv. Polym. Sci. (Hierarchical Macromolecular Structures: 60 Years after the Staudinger Nobel Prize I) 261 249-262 (2013) (DOI: 10.1007/12_2013_271)
  27. M. Sanjoh, Y. Miyahara, K. Kataoka, A. Matsumoto, Phenylboronic acids-based diagnostic and therapeutic applications. Anal. Sci. 30 111-117 (2014) (DOI: 10.2116/analsci.30.111)
  28. Y. Lee, K. Kataoka, Delivery of nucleic acid drugs. Adv. Polym. Sci. 249 95-134 (2012) (DOI: 10.1007/12_2011_129)
  29. K. Miyata, N. Nishiyama, K. Kataoka, Rational design of smart supramolecular assemblies for gene delivery: Chemical challenges in the creation of artificial viruses. Chem. Soc. Rev. 41 (7) 2562-2574 (2012) (DOI: 10.1039/C1CS15258K)
  30. K. Itaka, K. Kataoka, Progress and prospects of polyplex nanomicelles for plasmid DNA delivery. Curr. Gene Ther. 11 (6) 457-465 (2011) (DOI: 10.2174/156652311798192879)
  31. H. Cabral, N. Nishiyama, K. Kataoka, Supramolecular nanodevices: From design validation to theranostic nanomedicine. Acc. Chem. Res. 44 (10) 999-1008 (2011) (DOI: 10.1021/ar200094a)
  32. K. Miyata, R. J. Christie, K. Kataoka, Polymeric micelles for nano-scale drug delivery. React. Funct. Polym. 71 (3) 227-234 (2011) (DOI: 10.1016/j.reactfunctpolym.2010.10.009)
  33. Y. Vachutinsky, K. Kataoka, PEG-based polyplex design for gene and nucleotide delivery. Isr. J. Chem. 50 (2) 175-184 (2010) (DOI: 10.1002/ijch.201000018)
  34. H. Cabral, K. Kataoka, Multifunctional nanoassemblies of block copolymers for future cancer therapy. Sci. Technol. Adv. Mater. 11 (1) 014109 (2010) (DOI: 10.1088/1468-6996/11/1/ 014109)
  35. R. J. Christie, N. Nishiyama, K. Kataoka, Delivering the code: Polyplex carriers for deoxyribonucleic acid and ribonucleic acid interference therapies. Endocrinology 151 (2) 466-473 (2010) (DOI: 10.1210/en.2009-1045)
  36. M. Zhang, K. Kataoka, Nano-structured composites based on calcium phosphate for cellular delivery of therapeutic and diagnostic agents. Nano Today 4 (6) 508-517 (2009) (DOI: 10.1016/ j.nantod.2009.10.009)
  37. Y. Lee, K. Kataoka, Biosignal-sensitive polyion complex micelles for the delivery of biopharmaceuticals. Soft Matter 5 (20) 3810-3817 (2009) (DOI: 10.1039/b909934d)
  38. Y. Bae, K. Kataoka, Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers. Adv. Drug Deliv. Rev. 61 (10) 768-784 (2009) (DOI: 10.1016/j.addr.2009.04.016)
  39. K. Osada, R. J. Christie, K. Kataoka, Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery. J. R. Soc. Interface 6 S325-S339 (2009) (DOI: 10.1098/rsif.2008.0547.focus)
  40. R. Tong, D. A. Christian, L. Tang, H. Cabral, J. R. Baker,Jr., K. Kataoka, D. E. Discher, J. Cheng, Nanopolymeric Therapeutics. MRS Bull. 34 (6) 422-431 (2009) (DOI: 10.1557/mrs2009.118)
  41. N. Nishiyama, Y. Morimoto, W. -D. Jang, K. Kataoka, Design and development of dendrimer photosensitizer-incorporated polymeric micelles for enhanced photodynamic therapy. Adv. Drug Deliv. Rev. 61 (4) 327-338 (2009) (DOI: 10.1016/j.addr.2009.01.004)
  42. Y. Matsumura, K. Kataoka, Preclinical and clinical studies of anticancer agent-incorporating polymer micelles. Cancer Sci. 100 (4) 572-579 (2009) (DOI: 10.1111/j.1349-7006.2009.01103.x)
  43. K. Itaka, K. Kataoka, Recent development of nonviral gene delivery systems with virus-like structures and mechanisms. Eur. J. Pharm. Biopharm. 71 (3) 475-483 (2009) (DOI: 10.1016/j.ejpb.2008.09.019)
  44. W. -D. Jang, N. Nishiyama, K. Kataoka, Supramolecular assembly of photofunctional dendrimers for biomedical nano-devices. Supramol. Chem. 19 (4-5) 309-314 (2007) (DOI: 10.1080/10610270701324089)
  45. N. Nishiyama, W. -D. Jang, K. Kataoka, Supramolecular nanocarriers integrated with dendrimers encapsulating photosensitizers for effective photodynamic therapy and photochemical gene delivery. New J. Chem. 31 1074-1082 (2007) (DOI: 10.1039/b616050f)
  46. N. Nishiyama, K. Kataoka, Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol. Ther. 112 (3) 630-648 (2006) (DOI: 10.1016/j.pharmthera.2006.05.006)
  47. A. Harada, K. Kataoka, Supramolecular assemblies of block copolymers in aqueous media as nanocontainers relevant to biological applications. Prog. Polym. Sci. 31 (11) 949-982 (2006) (DOI: 10.1016/j.progpolymsci.2006.09.004)
  48. K. Osada, K. Kataoka, Drug and gene delivery based on supramolecular assembly of PEG-polypeptide hybrid block copolymers. Adv. Polym. Sci. 202 (Peptide Hybrid Polymers) 113-153 (2006) (DOI: 10.1007/12_084)
  49. S. Ueno, J. Ando, H. Fujita, T. Sugawara, Y. Jimbo, K. Itaka, K. Kataoka, T. Ushida, The state of the art of nanobioscience in Japan. IEEE Trans. NanoBiosci. 5 (1) 54-65 (2006) (DOI: 10.1109/TNB.2005.864022)
  50. N. Nishiyama, K. Kataoka, Nanostructured devices based on block copolymer assemblies for drug delivery: Designing structures for enhanced drug function. Adv. Polym. Sci. 193 (Polymer Therapeutics II) 67-101 (2006) (DOI: 10.1007/12_025)
  51. Y. Nagasaki, K. Kataoka, Ligand-installed PEGylated bionanosphere. IEE Proc.-Nanobiotech. 152 (2) 89-96 (2005) (DOI: 10.1049/ip-nbt:20055021)
  52. N. Nishiyama, Y. Bae, K. Miyata, S. Fukushima, K. Kataoka, Smart polymeric micelles for gene and drug delivery. Drug Discov. Today: Technologies 2 (1) 21-26 (2005) (DOI: 10.1016/j.ddtec.2005.05.007)
  53. W. -D. Jang, K. Kataoka, Bioinspired applications of functional dendrimers. J. Drug Deliv. Sci. Tech. 15 (1) 19-30 (2005) (DOI: 10.1016/S1773-2247(05)50003-0)
  54. H. Otsuka, Y. Nagasaki, K. Kataoka, PEGylated nanoparticles for biological and pharmaceutical applications. Adv. Drug Deliv. Rev. 55 (3) 403-419 (2003) (DOI: 10.1016/S0169-409X(02)00226-0)
  55. Y. Kakizawa, K. Kataoka, Block copolymer micelles for delivery of gene and related compounds. Adv. Drug Deliv. Rev. 54 (2) 203-222 (2002) (DOI: 10.1016/S0169-409X(02)00017-0)
  56. H. Otsuka, Y. Nagasaki, K. Kataoka, Self-assembly of block copolymers. Mater. Today 4 (3) 30-36 (2001) (DOI: 10.1016/S1369-7021(01)80036-5)
  57. K. Kataoka, A. Harada, Y. Nagasaki, Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv. Drug Deliv. Rev. 47 (1) 113-131 (2001) (DOI: 10.1016/S0169-409X(00)00124-1)
  58. H. Otsuka, Y. Nagasaki, K. Kataoka, Self-assembly of poly(ethylene glycol)-based block copolymers for biomedical applications. Curr. Opin. Colloid Interface Sci. 6 (1) 3-10 (2001) (DOI: 10.1016/S1359-0294(00)00082-0)
  59. Y. Nagasaki, K. Kataoka , Poly(silamine)s as intelligent materials. ChemTech 27 (3) 23-29 (1997)
  60. Y. Nagasaki, K. Kazama, E. Honzawa, M. Kato, K. Kataoka, T. Tsuruta, A hydrogel with rubber elasticity transition. Macromol. Symp. 109 (36th Microsymposium on Macromolecules High-Swelling Gels, 1995) 27-40 (1996) (DOI: 10.1002/masy.19961090104)
  61. Y. Nagasaki, K. Kataoka, An intelligent polymer brush. Trends in Polym. Sci. 4 (2) 59-64 (1996)
  62. G. S. Kwon, K. Kataoka, Block copolymer micelles as long-circulating drug vehicles. Adv. Drug Deliv. Rev. 16 (2-3) 295-309 (1995) (DOI: 10.1016/0169-409X(95)00031-2)
  63. K. Kataoka, Design of nanoscopic vehicles for drug targeting based on micellization of amphiphilic block copolymers. J. Macromol. Sci. - PURE APPL. CHEM. 31 (11) 1759-1769 (1994) (DOI: 10.1080/10601329408545880)
  64. K. Kataoka, G. S. Kwon, M. Yokoyama, T. Okano, Y. Sakurai, Block copolymer micelles as vehicles for drug delivery. J. Control. Release 24 (1-3) 119-132 (1993) (DOI: 10.1016/0168-3659(93)90172-2)
  65. K. Kataoka, Polymers for cell separation. CRC Critical Reviews in Biocompatibility 4 (4) 341-369 (1988)
  66. N. Yui, K. Kataoka, Y. Sakurai, Recent advances in thromboresistant materials. Med. Prog. Technol. 12 221-232 (1987) (DOI: 10.1007/978-94-009-3361-3_19)
  67. K. Kataoka, Y. Sakurai, T. Tsuruta, Microphase separated polymer surfaces for separation of B and T lymphocytes. Makromol. Chem. Suppl. 9 53-67 (1985) (DOI: 10.1002/macp.1985.020091985108)